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1. Introduction 
Ulcerative colitis (UC) is an inflammatory bowel disease related to chronic relapsing 
inflammation of the intestinal tract of unknown aetiology (Podolsky, 2003). Maintenance of 
colonic inflammation involves a network of inflammatory mediators resulting in a dramatic 
increase in the production of reactive oxygen species that contribute to the functional 
change characteristic of UC (Pavlick et al, 2002). Animal models provide evidence that 
altered cytokine (IL-1β) and eicosanoid secretion patterns may play a role in UC (Blumberg 
et al, 1999; Stenson, 2007). Eicosanoids, including leukotrienes generated by the 5-
lipoxygenase pathway (Murthy et al, 1997) and prostaglandins (PGs) produced by the 
cyclooxygenases COX-1 or COX-2, are lipid mediators implicated in the pathophysiology of 
UC (Funk, 2001).  
Inflammation in experimentally induced colitis is characterized by increased PGs such as 
PGE2 and PGD2. PGD2 (Ajuebor et al, 2000; Melgar et al, 2006) is further converted by 
dehydratation to 15-deoxy-12,14-PGJ2 (15d- PGJ2) (Monneret et al, 2002), a stable PG and 
putative endogenous PPAR ligand with cytoprotective and anti-inflammatory properties, 
and hence a new potential therapeutic target in inflammatory bowel diseases (Dubuquoy et 
al, 2006).  
7-Hydroxy-DHEA, the innate metabolite of dehydroepiandrosterone (DHEA), is normally 
produced in the colon and many other tissues (Doostzadeh & Morfin, 1996; Morfin & 
Courchay, 1994) but overproduced by IL-1β during the inflammatory process as shown in 
mice and humans (Dulos et al, 2004; Dulos et al, 2005). We have previously shown that pre-
treatment with DHEA and 7-hydroxy-DHEA resulted in protective anti-oxidant effects in 
the colon of healthy and colitis rats (Pelissier et al, 2004; Pelissier et al, 2006). 7-Hydroxy-
DHEA is converted by NADP(H)-dependent 11-hydroxysteroid dehydrogenase type 1 
(11-HSD1) to 7-hydroxy-DHEA through an oxido-reductive process via 7-oxo-DHEA 
(Muller et al, 2006b). Through this mechanism, 7-hydroxy-DHEA may inhibit 11-HSD1-
dependent production of inactive cortisone from active cortisol (Hennebert et al, 2007a). 
Epiandrosterone (EpiA), which is derived from DHEA, is also converted into 7-
hydroxylated metabolites (Kim et al, 2004). We have recently shown that 11-HSD1 is 
responsible for converting 7-hydroxy-EpiA into 7-hydroxy-EpiA (Chalbot & Morfin, 2005; 
Hennebert et al, 2007b), which is readily produced in small quantities in human tissues 
(Jacolot et al, 1981; Kim et al, 2004). 
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7β-Hydroxy-EpiA has been shown to exert neuroprotective effects in vivo at remarkably low 
doses in animal models of cerebral ischemia (Pringle et al, 2003) and Alzheimer's disease 
(Dudas et al, 2004). However, dose levels needed to demonstrate these effects are far below 
the concentrations necessary to inhibit the 11β-HSD1-dependent-cortisol transformation 
indicating that other mechanisms may be involved. 
Finally, studies in rheumatoid arthritis and brain injury models have shown that DHEA can 
modulate the expression of COX-2 mRNA or PGE2 synthesis (Malik et al, 2003; Sun et al, 
2006).  
Taken together, these finding suggest that certain 7-hydroxysteroids may play a role in the 
modulation of PGs production in inflammation. This role may permit to resolve 
inflammation in inflammatory bowel diseases.  
2. The resolution of inflammation 
Inflammatory resolution occurs after the sharp PGE2-driven inflammation process and is 
thought to result from cytoprotective PGD2 and 15d-PGJ2 action. A shift from arachidonic 
acid-derived PGE2 to PGD2 production occurs to these ends (Haworth & Buckley, 2007; 
Rajakariar et al, 2007) and is illustrated in Figure 1.  
Figure 1 outlines the native inflammation process and its relations to immunity onset and 
circulating steroid metabolism.  Inflammation-triggered increase in cellular cytochrome 
P450-7B1 which results in augmented 7-hydroxy-steroid production was shown both in a 
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Fig. 1. At the onset of inflammatory response, arachidonic acid (AA) is converted to PGH2 
via COX. In turn, PGE2, PGI2 and PGD2 are produced from PGH2 by synthases (PGE2S, 
PGI2S, PGD2S). PGD2 is transformed non-enzymatically (Sp) to 15d-PGJ2 which interacts 
with PPAR-. Non PPAR--mediated action of 15d-PGJ2 are not shown. 
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mouse model of rheumatoid arthritis and in humans with rheumatoid arthritis (Dulos et al, 
2004; Dulos et al, 2005). Due to this increase, competitive inhibition of the cellular 11-HSD1 
may occur (Muller et al, 2006a) through use of the enzyme for transformation of 7-
hydroxysteroid into 7-hydroxysteroids (Hennebert et al, 2007a; Muller et al, 2006b). Thus, 
the circulating inactive cortisone made available to the inflamed cells is not activated into 
cortisol which would quench the onset of immune processes. Our finding of a 7-hydroxy-
dehydroepiandrosterone-triggered increase of immune response in mice supports this 
relation to immunity onset (Morfin & Courchay, 1994). 
These basic facts led to questions relative to the effect of 7-hydroxysteroids on inflammation, 
PG metabolism, cell protection and related mechanisms of action. Answers were found 
through investigations using several models of inflammation in rats and humans.  
3. Choice in the 7-Hydroxysteroid used in treatments 
Among 7-hydroxysteroids, 7-hydroxy-epiandrosterone (7-hydroxy-EpiA) was selected 
because of its reported effects as a neuroprotector (Pringle et al, 2003). 7-Hydroxy-EpiA is a 
native steroid which derives from testosterone and dehydroepiandrosterone as reported 
(Niro et al, 2010) and illustrated in Figure 2. The chemical synthesis of 7-hydroxy-EpiA was 
carried out (Ricco et al, 2011) and provided 400 mg of the steroid which is available now for 
investigations in our group and abroad. Several doses of 7-hydroxy-EpiA (0.01, 0.1 and 1 
mg/kg) were used for the treatments. 
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Fig. 2. Epiandrosterone derives from testosterone and dehydroepiandrosterone (DHEA) and 
is a substrate for cytochrome P450-7B1 (2 EC 1.14.13.100) producing 7-hydroxy-
epiandrosterone which is inter-converted then into 7-hydroxy-epiandrosterone by 11-
hydroxysteroid dehydrogenase type 1 (3 EC 1.1.1.148). Other enzymes are 1. 3-hydroxy-5-
ene steroid dehydrogenase (EC 1.1.1.145, EC 5.3.3.1) 4. 17-hydroxysteroid dehydrogenase 
(EC 1.1.1.51) 5. Steroid 4-5-reductase (EC 1.3.99.5) 6. 3-hydroxysteroid dehydrogenase 
(EC 1.1.1.51).  
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4. Investigations in rats with dextran sodium sulphate-induced colitis  
4.1 Colitis induction and experimental design  
Male Wistar rats (180-200g) were acclimated for 7 days and were divided into 2 controls 
groups (one sham-treated and one treated) and 2 colitis groups (one sham-treated and one 
treated). Treatments with 7-hydroxy-EpiA were carried out for 7 days prior to colitis 
induction (Figure 3). Doses (0.01, 0.1 and 1 mg/kg) were dissolved in dimethyl sulfoxide 
and injected i.p. daily for 7 days.  Dimethyl sulfoxide alone was injected to the sham-treated 
animals. Colitis was then induced by addition of 5% dextran sodium sulphate (DSS) to 
drinking water for 7 days. Plain water was given to the control groups. Clinical and 
histological signs of colitis occurred in all the DSS-treated rats. Typically, all the rats 
exhibited symptoms of colitis and severe diarrhea 5 days after the onset of DSS treatment 
followed by rectal bleeding and shortening of the colon after 7 days. Increase in colonic 
myeloperoxidase activity indicated an invasion of the colonic mucosa by neutrophils 
(Hennebert et al, 2008). 
 
Fig. 3. Experimental design. DSS: 5% DSS in drinking water; DMSO: dimethyl sufoxide; 7-
OH-EpiA: 7-hydroxy-EpiA in DMSO. 
4.2 Histological examinations  
A portion (1 cm) of the proximal colon was fixed in 4% formaldehyde and embedded in 
paraffin. Tissue sections (5 µm) were stained either with hematoxylin/eosin or Alcian blue 
for evaluation of colonic damage and mucus goblet cells content, respectively.  
Major hallmarks of colonic inflammation, namely cryptic distorsion, neutrophil infiltration 
in the mucosal tissue (Figure 4B1), and loss of goblet cells which contained less mucins 
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(Figure 4B2) were apparent in the colitis group at day 13 and were more pronounced at day 
14 (Figure 4D1-4D2) when compared with sham-control group (Figure 4A1,A2 and C1,C2).  
The two low doses of 7-hydroxy-EpiA (0.01, 0.1 mg/kg) prevented the DSS-induced 
colonic damages as indicated by the suppression of diarrhea and rectal bleeding. The colon 
length reduction was less pronounced in the groups treated by the low steroid doses (0.01, 
0.1 mg/kg) than in the colitis group. All 7-hydroxy-EpiA doses (0.01, 0.1 and 1 mg/kg) 
antagonized mucus depletion in goblet cells (Figure 4E2,F2,G2) and improved histological 
changes such as the abnormality of crypts and neutrophil infiltration (Figure 4E1,F1,G1) 
(Hennebert et al, 2008).  
 
Fig. 4. Acute colitis induced by DSS: effect of 7-hydroxy-EpiA on colon injury. Histological 
appearance of rat colonic mucosa after hematoxylin/eosin  (A1-G1) or alcian blue stain (A2-
G2) at days 13 and 14: sham (A1,A2) and DSS-treated (B1,B2) at day 13; sham (C1,C2) and 
DSS-treated (D1,D2) at day 14; and 0.01 mg/kg 7-hydroxy-EpiA (E1,E2), 0.1 mg/kg (F1,F2) 
and 1 mg/kg (G1,G2) at day 14. No histological modification was present in sham animals 
(A and C) at days 13 and 14. Mucosal injury in DSS-induced colitis rats starting at day 13 
and being more pronounced at day 14 (D) was characterized by necrosis of the epithelium, 
focal ulceration, infiltration of inflammatory cells and mucin goblet cell depletion. 
Treatment with 7-hydroxy-EpiA (E-G) reduced the morphological alteration associated 
with DSS administration protecting the mucosal architecture. Magnification was 40x for all 
slices. 
4.3 7-Hydroxy-EpiA-induced changes in PG colonic tissue levels 
7-Hydroxy-EpiA treatments did not alter PGE2 and PGD2 colonic tissue levels in control 
rats without colitis (data not shown). DSS administration resulted into a marked increase of 
PGE2, PGD2 and 15d-PGJ2 colonic synthesis at day 13 (Figure  5). At day 14, PGE2 levels 
whereas PGD2 synthesis was increased and 15d-PGJ2 levels were reduced (Figure 5). 
7-Hydroxy-EpiA treatment in rats with DSS-induced colitis significantly decreased the 
colonic PGE2 synthesis at days 13 and 14 when compared with untreated colitis rats. The 
greatest decrease was observed with the lowest dose (0.01 mg/kg) which led to a return 
towards basal values (Figure 5A). PGD2 levels remained unchanged with the highest 
steroid-doses whereas the low doses (0.01 and 0.1mg/kg) caused a small but significant 
decrease (Figure 5B). Following the treatment with 7-hydroxy-EpiA and throughout colitis 
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induction, 15d-PGJ2 levels were maintained above control levels ranging from 5 to 14-fold 
increase (Figure 5C). Since 15d-PGJ2 results from the produced PGD2, addition of both PG 
levels may reflect the total production of PGD2. This leads to observations identical with 
those derived from 15d-PGJ2 measurements alone (Figure 4D). The decrease in 15d-PGJ2 
observed at the end of colitis induction underlies that 7-hydroxy-EpiA treatment produced 
large amounts of 15d-PGJ2 prior to colitis induction. This was confirmed after measurement 
of colonic 15d-PGJ2 during 7-hydroxy-EpiA treatment (Figure 5).  Thus, a 51-fold increase 
was obtained with the 0.1 mg/kg dose at day 2 (D2) and decreased progressively from D4 to 
D6 (increments ranging from of 44-fold to 5-fold) (Figures 5C and 6). Conclusion of these 
findings is that 7-hydroxy-EpiA treatments induced a shift from PGE2 to 15d-PGJ2 
production (Hennebert et al, 2008). 
 
Fig. 5. Effect of 7-hydroxy-EpiA on colonic synthesis of PGE2 (A), PGD2 (B), 15d-PGJ2 (C) 
and PGD2+15d-PGJ2 (D). Measurements were carried out in triplicate during DSS 
administration at days D11, D13 and D14. Data are expressed as mean ± S.E.M. with n=3-15 
(*) Dextran sodium sulphate-induced colitis group versus Sham-control group; (¤) 7-
hydroxy-EpiA treated group versus Dextran sodium sulphate-induced colitis group (p < 
0.05). 
4.4 7-Hydroxy-EpiA-induced changes in PG-producing enzymes 
Because significant modifications in prostaglandin levels were observed with DSS 
administration and 7β-hydroxy-EpiA treatments, we tested whether the expression of COX-
2, mPGES-1 and H-PGDS was altered by quantifying specific mRNA by real-time RT-PCR. 
Transcription of these genes was examined and related to that of the HPRT1 house-keeping 
gene (Hennebert et al, 2008).  
*
¤
A
0
2
4
6
8
D11 D13 D14
P
G
E
2
 (
n
g
/m
L
)
Control Colitis 0,01 0,1 1
*
¤
¤
¤¤¤
* *
B
0
0,2
0,4
0,6
0,8
D11 D13 D14
P
G
D
2
 (
n
g
/m
L
)
Control Colitis 0,01 0,1 1
*
*
¤
¤
¤
¤ 
¤ ¤ 
C
0
1
2
3
4
5
6
7
8
D11 D13 D14
1
5
d
-P
G
J2
 (
n
g
/m
L
)
Control Colitis 0,01 0,1 1
* 
* ¤ 
¤ 
¤ 
¤ ¤
¤
D
0
1
2
3
4
5
6
7
8
D11 D13 D14
P
G
D
2
 +
 1
5
d
-P
G
J
2
 (
n
g
/m
L
)
Control Colitis 0,01 0,1 1
www.intechopen.com
 
Resolution of Colitis-Associated Inflammation 
 
37 
 
Fig. 6. Colonic 15d-PGJ2 levels at various times during and after 7-hydroxy-EpiA treatment 
(D2-D9). Values are mean ± S.E.M. (n= 3-15) . (*) comparison to the sham-control group 
(p<0.05).  
In control rats without colitis, the daily 7β-hydroxy-EpiA treatment (0.1 mg/kg) induced a 
significant 1.5 fold increase in COX-2 mRNA levels at 15h followed by a decrease up to day 
4 and thereafter returned to basal values (Figure 7A). mPGES-1 mRNA expression increased 
transiently between 6h to 15h returning towards basal levels at day 2. H-PGDS mRNA 
expression remained similar to that in sham-control rats throughout the time course.  
After colitis induction, a 2.5 fold increase in COX-2 mRNA expression was observed at days 
13 and 14 of DSS administration (Figure 7B) while mPGES-1 mRNA was significantly 
augmented at day 13 only (Figure 7C). H-PGDS was not altered by colitis (Figure 7D). In 
conclusion, 7β-hydroxy-EpiA treatment (all doses) suppressed the increase in both COX-2 
and mPGES-1 mRNA synthesis in the colitis group from day 13 to day 14 (Figure 7). 
4.5 7-Hydroxy-EpiA overall effects on colitis 
Colitis was fully induced in untreated rats after DSS administration for 7 days. Treatment 
for 7 days with several doses of 7-hydroxy-EpiA prior to colitis induction led to a 
prevention of colitis onset. Examination of myeloperoxidase activity and oxidative stress 
markers such as carbonylated proteins and Tbars provided evidence of their decrease after 
steroid treatment (Hennebert et al, 2008). The preventive effects of 7-hydroxy-EpiA could 
result in part from the early increase of the prostaglandin 15d-PGJ2 that might contribute to 
down regulate the inflammatory response. 7-Hydroxy-EpiA triggered an increase in COX-
2 and m-PGES1 expression but depressed the elevation of colonic PGE2 synthesis in dextran 
sodium sulphate-treated rats. Thus, 7-hydroxy-EpiA triggered a shift from the PGE 
pathway towards the PGD pathway, causing increased production of 15d-PGJ2, the 
dehydrated stable metabolite of PGD2 (Scher & Pillinger, 2005). Our finding that small doses 
of 7-hydroxy-EpiA, an endogenous steroid produced in colon, can prevent colonic damage 
through a shift from PGE2 to PGD2 production via changes in COX-2 expression, followed 
by an increase of 15d-PGJ2 levels in the colon result from investigations carried out on a rat 
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Fig. 7. Colonic expression of COX-2, m-PGES1 and H-PGDS mRNA after 0.1 mg/kg 7-
hydroxy-EpiA treatment and before colitis induction (A). During colitis induction, mRNA 
levels for COX-2 (B), m-PGES-1 (C) and H-PGDS (C) were measured at days 11, 13 and 14. 
mRNA levels are expressed relative to that of HPRT1 standing at a basal level of 1 shown as 
a continuous line. (*) DSS-colitis versus basal level (p < 0.05). (**) DSS + 0.01, 0.1 and 1 
mg/kg 7-hydroxy-EpiA-treated group versus DSS-colitis group (p < 0.05). 
model where inflammation and colitis were obtained by dextran sodium sulphate 
administration. Two immediate questions arise from these findings: i) does this process, 
leading to the resolution of inflammation, occur in any inflammation? ii) is 7-hydroxy-
EpiA as efficient in humans as in rats when faced with inflammation? Answers to these 
questions were seek in human cell cultures. 
5. A model for inflammation studies in humans  
Addition of TNF- to cultures of human peripheral blood monocytes (PBMC) results into 
the cellular stress found in inflammatory conditions through production of mediators 
released from the eicosanoid pathway. These mediators include PGE2 that is associated with 
inflammation, and PGD2 and 15d-PGJ2 which are associated with the resolution of 
inflammation (Haworth & Buckley, 2007). Therefore, we used human PBMC cultured in the 
presence or absence of 0.01 µg/mL TNF- in order to test the effects of 7-hydroxy-EpiA on 
PG production (Le Mee et al, 2008). PBMC were cultivated either for 4 or 24 hours. RIA 
measurements were carried out for the PG levels released in the medium, and mRNA of the 
eicosanoid pathway were measured in cell extracts by quantitative PCR. All mRNA 
measurements were made relative to the expression of house-keeping gene HPRT1 (Le Mee 
et al, 2008). 
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5.1 7-Hydroxy-EpiA-induced a shift in PG production  
7-Hydroxy-EpiA addition to the medium induced no significant change in PG levels in 
PBMC cultured for 4 h. In marked contrast, significantly increased 15d-PGJ2 levels were 
obtained after cultivation for 24 h (Figure 8). This increment occurred both in the presence and 
in the absence of TNF-. A significant decrease in PGE2 levels was also obtained in the 
presence of TNF- only (Figure 8B). These findings indicated that 7-hydroxy-EpiA treatment 
of TNF--associated inflammation patterns were causative of a shift from PGE2 to 15d-PGJ2 
production. Since 15d-PGJ2 is a spontaneous dehydrated derivative of PGD2, production of 
PGD2 must have been increased along with the inflammation-related conditions for its 
conversion to 15d-PGJ2 (Le Mee et al, 2008). 7-Hydroxy-EpiA-triggered changes in the 
expression of the enzymes producing PGE2 and PGD2 had to be examined then. 
 
Fig. 8. PG levels released in the medium of human PBMC cultured for 24 h fortified with 1-
100 nM 7-hydroxy-EpiA. Cultures were carried out in the absence (A) or in the presence of 
TNF- (B). (*) significantly different from controls (p < 0.05).  
5.2 7-Hydroxy-EpiA-induced changes in eicosanoid pathway enzyme expression  
In addition to COX-2 and m-PGES1 which are responsible for arachidonic acid conversion to 
PGH2 and PGE2, respectively, we measured the mRNA levels of the known two enzymes 
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responsible for PGD2 production, namely H-PGDS and L-PGDS. No significant change in 
enzyme mRNA levels was found in cells culture with 7-hydroxy-EpiA for 4 h. In marked 
contrast, cultivation for 24 h led to significant differences in enzyme expression. Cultures 
without addition of TNF-showed that 7-hydroxy-EpiA significantly increased m-PGES1 
and decreased H-PGDS mRNA levels (Figure 9A). The findings were opposite in the 
presence of TNF-, with significant decrease in m-PGES1 and no change in H-PGDS mRNA 
levels (Figure 9B). No significant effect of 7-hydroxy-EpiA was found for COX-2 and L-
PGDS. These findings parallel well with PG levels measurements, and imply that the 7-
hydroxy-EpiA-triggered shift from PGE2 to 15d-PGJ2 production is mainly due to a lower 
expression of the m-PGES1 enzyme responsible for PGE2 production (Le Mee et al, 2008). 
 
Fig. 9. Measurement of COX-2, m-PGES1, H-PGDS and L-PGDS mRNA levels relative to the 
expression of house-keeping gene HPRT1. The human PBMC were cultured for 24 h without 
or with 1-100 nM 7-hydroxy-EpiA. Cultures were carried out in the absence (A) or the 
presence of TNF-. (*) significantly different from control group (p < 0.05). 
5.3 A putative specific receptor for 7-Hydroxy-EpiA  
Our findings that a 10-9 M dose of 7-hydroxy-EpiA was a trigger for the resolution of 
inflammation and for cellular protection led us to consider this steroid as a possible 
candidate for interference with a putative nuclear receptor. A precursor for 7-hydroxy-
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EpiA, namely 5-androstane-3,17-diol, was shown to bind preferentially to the estrogen 
receptor- (ER-) with agonistic activity and a Kd of 2 nM (20 times larger than for estradiol) 
(Kuiper et al, 1997).  Several reports inferred that ER- was involved in the protection 
against breast and prostate cancer (Dondi et al, 2010; Nilsson et al, 2001), and this led us to 
test this hypothesis on three breast cancer cell lines, namely, MCF-7, MDA-231 and SKBR-3 
(Niro et al, 2011).  
6. Tamoxifen-like effect of 7-Hydroxy-EpiA on breast cancer cell 
proliferation  
Among ERs, MCF-7 cells are known to express ER-, ER- and GPR30. MCF-7 cells 
proliferate in the presence of 10-8 M estradiol, and their proliferation is markedly inhibited 
by 10-6 M tamoxifen (TAM), even in the presence of estradiol. Cultivations in the presence of 
10-7-10-9 M 7-hydroxy-EpiA without TAM or estradiol inhibited MCF-7 cell proliferation to 
TAM levels, whereas use of both TAM and 7-hydroxy-EpiA, or estradiol + 7-hydroxy-
EpiA, decreased the proliferation below TAM levels (Figure 10A). These results indicated 
that 7-hydroxy-EpiA doses 10-103 lower than the TAM dose produced TAM-like effects on 
MCF-7 growth. In contrast, the MDA-231 cell receptor status is ER-GPR30+. Their 
proliferation was not increased by estradiol, and TAM effects were not as strikingly 
important as in MCF-7 cells (Niro et al, 2011).  
Cultivations of the MDA-231 cells in the presence of 10-7-10-9 M 7-hydroxy-EpiA without 
TAM or estradiol did not significantly change the proliferation patterns, whereas use of 
either estradiol + TAM or estradiol + 7-hydroxy-EpiA, decreased the proliferation much 
below TAM or estradiol levels (Figure 10B). In the case of SKBR-3 cells, le receptor status is 
GPR30+. SKBR-3 cell line proliferation was not significantly changed by estradiol, TAM or 
10-7-10-9 M 7-hydroxy-EpiA. Cultivations of SKBR-3 cells in the presence of estradiol + 7-
hydroxy-EpiA significantly decreased cell proliferation (Figure 10C) (Niro et al, 2011). 
The conclusions drawn from these studies imply the native 7-hydroxy-EpiA in the 
regulation of ER-mediated estrogen effects. As for TAM, the responsiveness of MCF-7 cells 
to 7-hydroxy-EpiA was better than for MDA-231 and SKBR-3 cells, and this implied that 
the antiproliferative and cytoprotective effects can be mediated by a receptor linked to one 
or several ERs. In any case, the receptor responsible for 7-hydroxy-EpiA effects needs to be 
identified and whether and how ERs are involved in the mechanism leading to cell 
protection require further examination. 
7. Pathophysiological significance of 7-Hydroxy-EpiA levels 
The first requirement for the production of native 7-hydroxy-EpiA is the presence of the 
steroid hormone substrate testosterone for generation of epiandrosterone by the classical 
steroid metabolism (Figure 2). Scarce studies were addressed to the levels of circulating 
epiandrosterone in humans. This may be due to ignorance of its fate in hormonal and 
physiological processes. Two key enzymes are required then for 7-hydroxy-EpiA production. 
One is CYP7B1 which provides a hydroxyl at the 7- position on epiandrosterone, and the 
second is 11-HSD1 which converts 7-hydroxy-EpiA into 7-hydroxy-EpiA. Both enzymes 
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Fig. 10. Tamoxifen-like effects of 7-hydroxy-EpiA on the proliferation of MCF-7 (A), MDA-
231 (B) and SKBR-3 cell lines. Cells (105) were seeded in triplicate in 24-well plates, and 
adherent cells were cultivated in 1 mL growth medium at 37°C, 95% humidity and in the 
presence of 5% CO2 for 72h. Estradiol (E2), 7-hydroxy-EpiA (7-EpiA) and tamoxifen 
(TAM) were administered in 5µL ethanol at the beginning of assays. Controls contained 5µL 
ethanol only. * Indicates a significant difference with controls (p < 0.05). 
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are ubiquitous in human tissues, and any deficit in their expression may lead to related 
pathologies. Their outcome may also be related to aging since the production and levels of 
steroid precursors such as DHEA and testosterone are known to be significantly decreased 
after the fifth decade in humans. These considerations would be strongly supported by 
precise measurements of the 7-hydroxy-EpiA circulating levels in humans. 
Finally, variations in the susceptibility for the development of diseases may depend on 7-
hydroxy-EpiA receptor availability and function (Nilsson & Gustafsson, 2002). The precise 
mechanism of action and the Ers involvement are to be deciphered in order to give a full 
support to 7-hydroxy-EpiA beneficial effects. 
8. Concluding remarks 
DHEA and testosterone-derived metabolites, namely epiandrosterone and 5-androstane-
3,17-diol, are substrates for the CYP7B1 and their 7-hydroxylated products are also 
converted into 7 epimer by the 11-HSD1. When assayed in rat colitis and inflamed human 
PBMC at doses 104 lower than circulating free DHEA or testosterone, 7-hydroxy-EpiA was 
shown to shift the PG metabolism from PGE2 to 15d-PGJ2 production, thus triggering the 
resolution of inflammation. In addition, 7-hydroxy-EpiA (1 nM) exerted the same effects as 
TAM (1 µM) on the proliferation of MCF-7, MDA-231 and SKBR-3 human beast cancer cell 
lines. These findings suggest that the observed effects of 7-hydroxy-EpiA could be 
mediated in part by ERs.  
This overview of recent studies implies that DHEA and/or testosterone are precursors for 
7-hydroxy-EpiA acting on inflamed tissues for the resolution of inflammation through a 
putative receptor. CYP7B1 and 11-HSD1 are two key enzymes involved in 7-hydroxy-
EpiA production, and their expression in colitis and other inflammatory diseases could be a 
rewarding target in further studies. 
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